Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

NCT: NCT06310031 · RECRUITING

NCT IDNCT06310031
StatusRECRUITING
Start Date2024-10-28
SponsorBrioHealth Solutions, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑